All News

Viaskin Peanut (DBV Technologies) achieved durable, long-term clinical benefit in peanut-allergic children.

Individuals with a history of heart disease may be at an increased risk of developing kidney failure.

In a new lawsuit, CVS, Walgreen, Rite Aid, and other major pharmacy chains said that they are not to blame in federal opioid litigation

Overall cancer death rates declined by 29% over a 26-year time period, with the largest single-year drop on record reported from 2016 to 2017.

Prediabetes can increase the risk the risk of developing type 2 diabetes.

Are the benefits of lowering systolic blood pressure to less than 130 mm Hg the same for those aged 80 years and older as they are for younger patients?

What are some of the factors affecting whether a brand-name drug has generic competition?

AstraZeneca’s supplemental New Drug Application for dapagliflozin (Farxiga) has been granted Priority Review by the FDA.

The critical role of distributors amid natural disasters, and strategies to protect and maintain the pharma supply chain

The New Drug Application is seeking approval for ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine for the treatment of HIV in adults.

Due to ongoing insulin affordability challenges, Novo Nordisk is offering new cost assistance options for patients with diabetes.

A new study examined diabetes as an independent predictor of heart failure. 

A 2016 California policy that eliminated non-medical vaccination exemptions for schoolchildren was linked to an increase in vaccine coverage.

Pharmacies can play an important role in raising awareness about efficient medication disposal methods.

Olaparib (Lynparza, Merck and AstraZeneca) is approved for the maintenance treatment of adult patients with germline BRCA-mutated metastatic pancreatic cancer.

Patients with diabetes are at risk for complications from vaccine-preventable diseases, making immunization especially critical.

In 2020, we know there will be a renewed focus on collaborating across health care specialties while reducing costs.

The approvals were granted to generic apixaban applications from Micro Labs Limited and Mylan Pharmaceuticals Inc.

Our most-read FDA approval articles from 2019. 

Walgreens, CVS Health, and Rite Aid are supporting the recently-launched “Ready, Set, PrEP” program.

Albertsons is expanding its partnership with Genomind to offer patients genetic testing to guide mental health medication management.

Many in community pharmacy worry that there are too many pharmacists for not enough jobs-whether it’s true or not is up for debate.

Simon Murray, MD, recently spent the day with Chris Castagna, RPh, an independent pharmacist.

Ongoing threats to the safety of intravenous (IV) drug delivery include drug shortages and lack of IV product standardization, according to an expert panel.

Initiating conversation takes time and effort.

Invasive methods did not perform better than drug treatment in patients with stable ischemic heart disease

Ubrogepant (Ubrelvy) is the first oral calcitonin gene-related peptide receptor antagonist approved by the FDA for the acute treatment of migraine.